全球细胞健康筛查市场 – 行业趋势及 2029 年预测

细胞健康筛查市场分析和规模

据世界卫生组织报告，全球慢性病数量正在增加。2001年，慢性病占全球疾病总负担的46%左右，占全球5650万死亡人数的60%。预计全球慢性病数量的增加将推动市场扩张。

Data Bridge Market Research 分析认为，2021 年细胞健康筛查市场规模为 22.6 亿美元，到 2029 年将飙升至 57.2 亿美元，预计在 2022 年至 2029 年的预测期内，复合年增长率将达到 12.30%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

细胞健康筛查市场范围和细分      

Market Definition

Cellular toxicity, fat mass, cellular health and function, intra and extracellular fluid levels, and muscle mass quality can all be determined with the help of cellular health screening.

Cellular Health Screening Market Dynamics

Drivers

• Rise in chronic diseases

The market is anticipated to develop faster as telomere performance programmes become more widely adopted. The market for cellular health screening will grow more quickly between 2022 and 2029 due to a number of additional factors, including an increase in chronic disease cases, an increase in research activities, a growing emphasis on healthy life expectancy, an increase in the population's average age, and an increase in the adoption of digital testing technologies.

• Rise in geriatric population

Growing geriatric population and consequent growth in the need for cellular health screening, rising geriatric population, growing adoption of the direct-to-consumer approach, growing importance of healthy life expectancy (HALE), rising government focus towards preventive healthcare, increasing telomere performance programmes for leading a healthy life, and growing burden of chronic diseases are expected to drive the growth of this market.

Opportunities

The need for testing solutions based on preventative healthcare has increased as a result of an increase in awareness campaigns by organisations around the world. One of the major key factors anticipated to propel market expansion in the near future is collaboration efforts made by organisations like the WHO, CDC, U.S. Preventive Services Task Force, and National Cervical Cancer Coalition to promote cervical cancer screening.

Restraints/Challenges

On the other hand, rising problem associated with the transport of samples, unfavourable reimbursement policies and difference in the cost kit offered by different organization is expected to hamper the market's growth rate.

This cellular health screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cellular health screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Cellular Health Screening Market

Market participants noticed a drop in their sales and base testing volume as a result of the COVID-19 epidemic. Additionally, the pandemic-related government mandates and restrictions on the transportation, export, and import of goods, raw materials, etc. disrupt the supply chain. The demand has decreased as a result, but many businesses have diversified their product lines to include COVID-19 molecular and antibody testing, which can equally counteract the decline in base testing volume.

Global Cellular Health Screening Market Scope

The cellular health screening market is segmented on the basis of type, sample type, and sample collection site. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Single Test Panels
• Telomere Tests
• Oxidative Stress Tests
• Inflammation Tests
• Heavy Metals Tests
• Multi-test Panels

Sample Test

• Blood
• Saliva
• Serum
• Urine

Collection Sites

• Home
• Office
• Hospital
• Diagnostic Labs

 Cellular Health Screening Market Regional Analysis/Insights

The cellular health screening market is analysed and market size insights and trends are provided by country, type, sample type, and sample collection site as referenced above.

The countries covered in the cellular health screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cellular health screening market due to the growing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising ageing population and increasing government initiatives to enhance the healthy lifestyles.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

竞争格局和细胞健康筛查市场份额分析

细胞健康筛查市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对细胞健康筛查市场的关注有关。

细胞健康筛查市场的一些主要参与者包括：

• Genova Diagnostics（美国）
• 端粒诊断（美国）
• 寿命（西班牙）
• Quest Diagnostics Incorporated（美国）
• 重复诊断（加拿大）
• SpectraCell Laboratories Inc.（美国）
• Zimetry（美国）
• 细胞科学系统（美国）
• Titanovo, Inc.（美国）
• Segterra, Inc.（美国）
• 美国实验室控股公司（美国）
• BioReference（美国）
• Immundiagnostik AG（德国）
• 克利夫兰心脏实验室公司（美国）

SKU-53060